Effects of Ezetimibe Add-On to Statin Therapy on Adipokine Production in Obese and Metabolic Syndrome Patients With Atherosclerosis.
Phase of Trial: Phase II
Latest Information Update: 09 Mar 2017
At a glance
- Drugs Ezetimibe; HMG-CoA reductase inhibitors
- Indications Hypercholesterolaemia; Hyperlipoproteinaemia type II; Sitosterolaemia
- Focus Biomarker; Pharmacodynamics
- 07 Jun 2017 Biomarkers information updated
- 24 Nov 2010 Actual end date (Apr 2009) added as reported by ClinicalTrials.gov.
- 24 Nov 2010 Additional lead trial centre identified as reported by ClinicalTrials.gov.